Alesta Yatırım

Alesta Yatirim is an Istanbul-based early-stage investor backing local Turkish founders across software and technology sectors, with pre-seed, seed, and early Series A checks in the $250K to $1M range. The firm’s healthcare interest is concentrated in digital health and health IT software, and Alesta is not positioned as an AI-native specialist; the lens is fundamentally commercial and locally focused. Within the Turkish venture landscape, Alesta sits in the cohort of broad-based local funds that have been deploying capital across the Istanbul ecosystem for years, with a portfolio that spans multiple sectors and stages rather than a tight thematic focus. The geographic focus is Turkey with selective international expansion for the strongest companies. The right founder profile is a Turkish technical founder building a digital health or health IT software business with early commercial traction inside Turkey and a credible path to either regional or international scale. The wrong fit is a deep-tech biotech, a research-stage AI platform, or a US-first SaaS company that treats Turkey as an afterthought; Alesta’s mandate is concentrated in local Turkish opportunities. The right entry path is through Istanbul founder networks, through Turkish startup ecosystem programs at Tubitak and KOSGEB, through Endeavor Turkey, and through warm introductions from co-investors at firms like 212, TechOne, and Logo Ventures. When pitching, lead with the Turkish commercial reality, the unit economics, the founder-market fit, and the path to international scale, then layer in the technology narrative. Avoid generic global pitches that do not engage with Turkish market specifics. Caveats: Alesta is a generalist local fund rather than a healthcare specialist, and the firm’s healthcare-specific operating expertise is limited, so founders should layer clinical-domain advisors and specialist co-investors onto the cap table. The Turkish macro environment also affects how founders structure capital, and dollar-denominated rounds with offshore holding structures are increasingly the norm. Use Alesta as a locally credible early partner that anchors your Turkish healthtech company in the Istanbul ecosystem and creates inbound from regional and international Series A investors as the metrics warrant.